Truist Financial’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-896,658
Closed -$22.4M 2740
2022
Q3
$22.4M Buy
896,658
+57,335
+7% +$1.43M 0.04% 330
2022
Q2
$21M Buy
839,323
+24,649
+3% +$617K 0.04% 359
2022
Q1
$20.4M Buy
814,674
+602,912
+285% +$15.1M 0.03% 422
2021
Q4
$5.32M Sell
211,762
-11,404
-5% -$288K 0.01% 867
2021
Q3
$5.65M Buy
223,166
+65,446
+41% +$1.66M 0.01% 833
2021
Q2
$4.01M Buy
157,720
+18,958
+14% +$482K 0.01% 974
2021
Q1
$3.53M Buy
138,762
+1,421
+1% +$36.2K 0.01% 987
2020
Q4
$3.51M Buy
137,341
+26,858
+24% +$687K 0.01% 946
2020
Q3
$2.83M Buy
110,483
+29,055
+36% +$745K 0.01% 939
2020
Q2
$2.09M Buy
81,428
+5,865
+8% +$149K ﹤0.01% 1006
2020
Q1
$1.87M Buy
75,563
+2,060
+3% +$51.7K ﹤0.01% 1001
2019
Q4
$1.86M Buy
+73,503
New +$1.86M ﹤0.01% 1164

Other funds holding IBDN

Truist Financial's IBDN Position: Q4 2022 in Review

Truist Financial sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 896,658 shares — an estimated $22.4M sold.

Truist Financial first reported a position in IBDN in Q4 2019 and held it in 12 quarters. The position peaked at $22.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Truist Financial reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Truist Financial sold 896,658 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $22.4M.
  • Truist Financial first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q4 2019 and held it in 12 quarters.
  • Truist Financial's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $22.4M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Truist Financial's 13F filing for Q4 2022, filed 17 Feb 2023.